Smith & Nephew PLC logo

Smith & Nephew PLC

OTCPK:SNNUF (UK)  
$ 11.93 0 (0%) 11:09 PM EST
40.62
P/B:
2.05
Market Cap:
$ 10.53B
Enterprise V:
$ 13.22B
Volume:
711.00
Avg Vol (2M):
2.93K
Also Trade In:
Volume:
711.00
Avg Vol (2M):
2.93K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SNNUF ( Smith & Nephew PLC ) from 2009 to Apr 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Smith & Nephew PLC stock (SNNUF) PE ratio as of Apr 19 2024 is 40.62. More Details

Smith & Nephew PLC (SNNUF) PE Ratio (TTM) Chart

To

Smith & Nephew PLC (SNNUF) PE Ratio (TTM) Historical Data

Total 1211
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Smith & Nephew PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-19 39.6 2024-02-14 44.7
2024-04-18 39.6 2024-02-13 45.4
2024-04-17 39.6 2024-02-12 45.5
2024-04-16 40.1 2024-02-09 45.7
2024-04-15 40.1 2024-02-08 47.3
2024-04-12 40.1 2024-02-07 47.3
2024-04-11 40.8 2024-02-06 46.6
2024-04-10 41.0 2024-02-05 46.6
2024-04-09 41.0 2024-02-02 44.9
2024-04-08 39.5 2024-02-01 46.4
2024-04-05 39.5 2024-01-31 47.4
2024-04-04 39.5 2024-01-30 46.4
2024-04-03 39.5 2024-01-29 46.4
2024-04-02 40.9 2024-01-26 45.0
2024-04-01 40.9 2024-01-25 45.0
2024-03-28 40.9 2024-01-24 45.5
2024-03-27 42.2 2024-01-23 45.5
2024-03-26 42.2 2024-01-22 45.5
2024-03-25 42.2 2024-01-19 45.5
2024-03-22 42.2 2024-01-18 45.5
2024-03-21 42.7 2024-01-17 45.5
2024-03-20 44.3 2024-01-16 45.5
2024-03-19 44.3 2024-01-12 45.6
2024-03-18 44.3 2024-01-11 45.8
2024-03-15 44.3 2024-01-10 45.8
2024-03-14 45.5 2024-01-09 44.5
2024-03-13 45.5 2024-01-08 44.5
2024-03-12 46.5 2024-01-05 44.8
2024-03-11 46.5 2024-01-04 44.8
2024-03-08 44.3 2024-01-03 44.7
2024-03-07 44.3 2024-01-02 45.3
2024-03-06 44.3 2023-12-29 46.0
2024-03-05 44.3 2023-12-28 46.0
2024-03-04 44.3 2023-12-27 52.4
2024-03-01 44.3 2023-12-26 52.4
2024-02-29 44.4 2023-12-22 56.3
2024-02-28 47.1 2023-12-21 52.1
2024-02-27 47.1 2023-12-20 51.6
2024-02-26 47.1 2023-12-19 51.6
2024-02-23 47.1 2023-12-18 52.6
2024-02-22 47.1 2023-12-15 53.1
2024-02-21 47.1 2023-12-14 55.6
2024-02-20 44.7 2023-12-13 53.3
2024-02-16 44.7 2023-12-12 52.3
2024-02-15 44.7 2023-12-11 53.2

Smith & Nephew PLC (SNNUF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.